Some patients with highly drug-resistant tuberculosis could benefit from a shorter treatment with fewer drugs, while others ...

Jaipur: In the state, 2.3 lakh people were found with Tuberculosis (TB) symptoms during screening campaign launched on June 25, 2025. These suspected .

Improving the health outcomes of people living with HIV through patient care and research into better prevention, early diagnosis, and effective treatment strategies for both HIV and TB, including ...

If TB and HIV/AIDS reporting began as histories of resistance, the story was very different when it came to cancer reporting, which lagged far behind infectious disease surveillance.

IDSA and HIVMA urged lawmakers to also preserve crucial infrastructure and other programs that support PEPFAR's ...

Gilead announced a deal to get its groundbreaking HIV prevention drug to lower income countries. Notably, the deal does not ...

The country isn’t getting extra money from the Global Fund to Fight Aids, TB and Malaria; it has to use cash from a grant it ...

TB is the leading cause of death among those with HIV /AIDS worldwide. According to the WHO, in 2023, 161,000 people died of HIV-associated TB.

New data demonstrated that long-acting cabotegravir was preferable to daily dolutegravir/lamivudine in treatment-naive people living with HIV.

Global health leaders and advocates challenged attendees of IAS to support the work of the partnerships that are creating patient-focused innovations for HIV prevention and treatment.

He saw his first AIDS patient in 1983, when there was no local infrastructure to address the disease, so he developed a groundbreaking regional rural HIV program.